Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Relationship of the curative effects of gefitinib on non-small cell lung carcinoma to gender and to epithelial growth factor receptor status].

Zhonghua yi xue za zhi - 10 Oct 2006

Xu Chong-rui, Lin Jia-ying, Wang Zhen, Zhou Qing, Zhang Guo-chun, Wang Kun, Yang Xue-ning, Chen Gang, Yang Jin-ji, Huang Yu-juan, Liao Ri-qiang, Wu Yi-long

Abstract excerpt

OBJECTIVE: To investigate the mutation of epithelial growth factor receptor (EGFR) gene in the non-small cell lung carcinoma (LSCLG) patients with different genders and the relationship between the gender of LSCLG patients and the curative effects of gefitinib, an specific tyrosine kinase. METHODS: Tumor specimens were obtained from 135 NSCLC patients, 94 males (78.7% smoking) and 41 females (17.1% smoking), of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to Gefitinib

Share to Lung Neoplasms

Share to Quinazolines

Share to Sex Factors

Share to Treatment Outcome

Source

Identifiers

PMID: 17198584

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Relationship of the curative effects of gefitinib on non-small cell lung carcinoma to gender and to epithelial growth factor receptor status].PMID 17198584Read ↗

[Epithelial growth factor receptor mutation status to the effective of survival in non-small cell lung cancer after surgery].Semantic proximity Read ↗

[Exon-dependent Subgroup-analysis of the Non-interventional REASON-Study: PFS and OS in EGFR-mutated NSCLC Patients Treated with Gefitinib or Chemotherapy].Semantic proximity Read ↗

The relationship between epidermal growth factor receptor mutations and clinicopathologic features in non-small cell lung cancers.Semantic proximity Read ↗

[Gefitinib and epidermal growth factor receptor gene mutation].Semantic proximity Read ↗

Sensitivity to epidermal growth factor receptor tyrosine kinase inhibitors in males, smokers, and non-adenocarcinoma lung cancer in patients with EGFR mutations.Semantic proximity Read ↗

[Relationship between EGFR and K-ras mutations and clinicopathological characteristics and response to erlotinib treatment in 301 Chinese patients with non-small cell lung cancer].Semantic proximity Read ↗

[Epidermal growth factor receptor gene mutations and clinicopathologic correlation in 309 patients with non-small cell lung cancer].Semantic proximity Read ↗

The characterization of gefitinib sensitivity and adverse events in patients with non-small cell lung cancer.Semantic proximity Read ↗

Epidermal growth factor receptor mutations and the clinical outcome in male smokers with squamous cell carcinoma of lung.Semantic proximity Read ↗

[Establishment of a model to assess the clinical efficacy of Gefitinib in treatment of non-small cell lung cancer].Semantic proximity Read ↗

[Relationship of epidermal growth factor receptor gene mutations, clinicopathologic features and prognosis in patients with non-small cell lung cancer].Semantic proximity Read ↗

[Molecular targeted therapy--non-small-cell lung cancer and gefitinib].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.